The Stool DNA Test: An Emerging Technology in Colorectal Cancer Screening

Gastroenterology Nursing

Volumn 28, Issue 1, 2005, Pages 28-32

  Greenwald, Beverly ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

COLORECTAL TUMOR; COMPARATIVE STUDY; FECES; FEMALE; FORECASTING; GENETICS; HUMAN; MALE; MASS SCREENING; METHODOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY; UNITED STATES;

COLORECTAL NEOPLASMS; DNA, NEOPLASM; FECES; FEMALE; FORECASTING; HUMANS; MALE; MASS SCREENING; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 17844392073     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/00001610-200501000-00007     Document Type: Article

References (32)

1. Agency for Health Care Policy and Research. (2003). Retrieved December 30, 2003, from
2. Ahlquist, D. A. (2000). Molecular stool screening for colorectal cancer: Using DNA markers may be beneficial, but large scale evaluation is needed. British Medical Journal, 321(7256), 254-255.
3. Ahlquist, D. A. (2002). Stool-based DNA tests for colorectal cancer: Clinical potential and early results. Reviews in Gastroenterological Disorders, 2(Suppl. 1), S20-S26.
4. Ahlquist, D. A., & Shuber, A. P. (2002). Stool screening for colorectal cancer: Evolution from occult blood to molecular markers. Clinica Chimica Acta, 315(1-2), 157-168.
5. Barkley, M. (2003, August 14). LabCorp offering new test to detect colorectal cancer: The DNA-based test is now available nationwide. Greensboro News Record, p. B5. Retrieved May 3, 2004, from
6. Bond, J. H. (2002). Fecal occult blood test screening for colorectal cancer. Gastrointestinal Endoscopy Clinics of North America, 12(1), 11-21.
7. Brooks, D. (2004). Colon cancer screening: The right tests. Clinical Advisor, 7(4), 23-31.
8. Center for Disease Control and Prevention. (2003). Retrieved April 2, 2003, from
9. Cole, S. R., & Young, G. P. (2001). Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer. Medical Journal of Australia, 175(4), 195-198.
10. Crespi, M., & Lisi, D. (2002). Is colorectal cancer screening by fecal occult blood feasible? Annals of Oncology, 13(1), 47-50.
11. Fearon, E. R., & Vogelstein, B. A. (1990). A genetic model for colorectal tumorigenesis. Cell, 61(5), 757-767.
12. Helm, J., Choi, J., Sutphen, R., Barthel, J. S., Albrecht, T. L., & Chirikos, T. N. (2003). Current and evolving strategies for colorectal cancer screening. Cancer Control, 10(3), 193-204.
13. Levin, B., Brooks, D., Smith, R. A., & Stone, M. (2003). Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA: A Cancer Journal for Clinicians, 53(1), 44-55.
14. Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M., & Ederer, F. (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. New England Journal of Medicine, 328(19), 1365-1371.
15. Mandel, J. S., Church, T. R., Bond, J. H., Ederer, F., Geisser, M. S., Mongin, S. J., Snover, D. C., & Schuman, L. M. (2000). The effect of fecal occult-blood screening on the incidence of colorectal cancer. New England Journal of Medicine, 343(22), 1603-1607.
16. McCance, K. L. & Roberts, L. K. (2002). Biology of cancer. In K. L. McCance & S. E. Huether (Eds.), Pathophysiology: The biological basis for disease in adults & children (4th ed., pp. 290-333). St. Louis, MO: Mosby, Inc.
17. PreGen-Plus. (2003). Retreived April 5, 2004, from
18. PreGen-Plus colorectal cancer detection. (2003). Retrieved April 5, 2004, from
19. PreGen-Plus fact sheet. (2003). Retrieved April 5, 2004, from
20. PreGen-Plus: Non-invasive colorectal cancer screening. (2004). Retrieved May 3, 2004, from
21. Ransohoff, D. F., & Lang, C. A. (1997a). Clinical guideline part I: Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening. Annals of Internal Medicine, 126(10), 808-810.
22. Ransohoff, D. F., & Lang, C. A. (1997b). Clinical guideline part II: Screening for colorectal cancer with the fecal occult blood test, a background paper. Annals of Internal Medicine, 126(10), 811-822.
23. Rex, D. (2003, November supplement). Clinical data on stool-based colorectal cancer screening test. Female Patient, 6s-8s.
24. Robinson, M. H. E., Pye, G., Thomas, W. M., Hardcastle, J. D., & Mangham, C. M. (1994). Haemoccult screening for colorectal cancer: The effect of dietary restriction on compliance. European Journal of Surgical Oncology, 20(5), 545-548.
25. Saito, H. (1996). Screening for colorectal cancer by immunochemical fecal occult blood testing. Japanese Journal of Cancer Research, 87(10), 1011-1024.
26. Smith, R. A., von Eschenbach, A. C., Wender, R., Levin, B., Byers, T., Rothenberger, D., et al. (2001). American Cancer Society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA: A Cancer Journal for Clinicians, 51(1), 38-75.
27. Smith, R. A., Cokkinides, V., & Eyre, H. J. (2004). American Cancer Society guidelines for the early detection of cancer, 2004. CA: A Cancer Journal for Clinicians, 54(1), 41-52.
28. Smith, R. A., von Eschenbach, A. C., Wender, R., Levin, B., Byers, T., Rothenberger, D., Brooks, D., Creasman, W., Cohen, C., Runowicz, C., Saslow, D., Cokkinides, V., & Eyre, H. (2001). American Cancer Society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA: A Cancer Journal for Clinicians, 51(1), 38-75.
29. Tagore, K. S., Lawson, M. J., Yucaitis, J. A., Gage, R., Orr, T., Shuber, A. P., & Ross, M. E. (2003). Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia. Clinical Colorectal Cancer, 3(1), 47-53.
30. Vernon, S. W. (1997). Participation in colorectal cancer screening: A review. Journal of the National Cancer Institute, 89(19), 1406-1422.
31. Wineman, A. P. (2003). Screening for colorectal cancer: Guidelines for choosing the appropriate test for each patient. Postgraduate Medicine, 113(2), 49.
32. Wong, W. M., Lam, S. K., Cheung, K. L., Tong, T. S. M., Rozen, P., Young, G. P., et al. (2003). Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population. Cancer, 97(10), 2420-2424.